Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials

Background: The pleiotropic efficacy of SGLT2is in patients with different eGFR levels has not been well-understood. This systematic review and meta-analysis assessed the disparities in the efficacy and safety of SGLT2i treatment across stratified renal function. Methods: We searched four databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Suiyuan, Lin, Chu, Cai, Xiaoling, Zhu, Xingyun, Lv, Fang, Yang, Wenjia, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723253/
https://www.ncbi.nlm.nih.gov/pubmed/36483741
http://dx.doi.org/10.3389/fphar.2022.1018720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723253/
https://www.ncbi.nlm.nih.gov/pubmed/36483741
http://dx.doi.org/10.3389/fphar.2022.1018720

Ejemplares similares